[Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87].
Kallage, V
[Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87]. [electronic resource] - Klinische Padiatrie - 250-9 p. digital
Publication Type: Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
0300-8630
10.1055/s-2008-1043797 doi
Acute Disease
Adolescent
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow Transplantation
Child
Cytarabine--administration & dosage
Drug Administration Schedule
Drug Resistance, Neoplasm
Etoposide--administration & dosage
Female
Humans
Infant, Newborn
Leukemia, Myeloid--drug therapy
Male
Remission Induction
Survival Analysis
Treatment Failure
[Prognosis, treatment completion, and complications in nonresponders in the study AML-BFM87]. [electronic resource] - Klinische Padiatrie - 250-9 p. digital
Publication Type: Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
0300-8630
10.1055/s-2008-1043797 doi
Acute Disease
Adolescent
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow Transplantation
Child
Cytarabine--administration & dosage
Drug Administration Schedule
Drug Resistance, Neoplasm
Etoposide--administration & dosage
Female
Humans
Infant, Newborn
Leukemia, Myeloid--drug therapy
Male
Remission Induction
Survival Analysis
Treatment Failure